Last Updated: October 27, 2026

Details for Patent: 9,265,765


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,265,765
Title:7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapy
Abstract:This disclosure relates, at least in part, to a method of treatment. In one embodiment, the method of treatment comprises administering to a subject in need of such treatment a first therapeutic agent including compound (1): or a pharmaceutically acceptable salt thereof in combination with a second therapeutic agent, wherein the first therapeutic agent and the second therapeutic agent are administered either simultaneously or sequentially.
Inventor(s):Martin Stogniew, Joshua E. Allen, Richard S. Pottorf, Bhaskara Rao Nallaganchu, Gary Olson
Assignee: Jazz Pharmaceuticals Ireland Ltd , Provid Pharmaceuticals Inc
Application Number:US14/208,657
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 9,265,765

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Chimerix MODEYSO dordaviprone hydrochloride CAPSULE;ORAL 219876-001 Aug 6, 2025 RX Yes Yes 9,265,765 ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,265,765

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014244117 ⤷  Start Trial
Australia 2014349150 ⤷  Start Trial
Australia 2019201896 ⤷  Start Trial
Australia 2020200875 ⤷  Start Trial
Australia 2020233606 ⤷  Start Trial
Australia 2022203043 ⤷  Start Trial
Australia 2024278350 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.